Literature DB >> 16489176

Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus.

M C Boelens1, A van den Berg, I Vogelzang, J Wesseling, D S Postma, W Timens, H J M Groen.   

Abstract

BACKGROUND: Changes in epithelial cell interactions have been implicated in carcinogenesis, tumour invasion and metastasis. AIM: To screen for altered expression of epithelial adhesion genes in lung cancer development.
METHODS: Gene expression profiles were assessed with cDNA expression arrays in eight non-small cell lung cancer (NSCLC) and eight normal bronchi obtained from the same patient. Immunohistochemistry (IHC) and RNA in situ hybridisation (ISH) were used to confirm the most prominently expressed adhesion molecules and to investigate their distribution at protein and mRNA levels.
RESULTS: 43 differentially expressed cancer-related genes were identified in adenocarcinoma, squamous cell carcinoma (SCC) and normal bronchus. Five of these genes are related to epithelial adhesion-that is, integrin alpha3 (ITGA3), integrin beta4 (ITGB4), desmoplakin I and II (DSP), plakoglobin, and desmocollin 3 (DSC3). ITGA3 and ITGB4, showing predominantly cell-matrix staining, were up regulated in adenocarcinoma and SCC, respectively. ITGB4 also showed strong staining in SCC with IHC and ISH. Components of the desmosome adhesion complex DSP, plakoglobin and DSC3 were strongly up regulated in SCC and showed a distinct cell-cell staining pattern. DSP and plakoglobin were predominantly present at central, more differentiated tumour cells, whereas DSC3 showed a stronger staining in the peripheral basal cells of SCC tumour areas.
CONCLUSIONS: Lack of cellular adhesion may have an important role in the metastatic potency of a primary tumour. A possible association of strong presence and normal-distributed desmosomal molecules in SCC with the less frequent and late pattern of metastasis in SCC as compared with adenocarcinoma is suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489176      PMCID: PMC1955047          DOI: 10.1136/jcp.2005.031443

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  30 in total

Review 1.  Molecular diversity of plaques of epithelial-adhering junctions.

Authors:  C M Borrmann; C Mertens; A Schmidt; L Langbein; C Kuhn; W W Franke
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Desmosomal adhesion regulates epithelial morphogenesis and cell positioning.

Authors:  S K Runswick; M J O'Hare; L Jones; C H Streuli; D R Garrod
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

Review 3.  Desmosomal cadherins.

Authors:  David R Garrod; Anita J Merritt; Zhuxiang Nie
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

Review 4.  Desmosomal adhesion: structural basis, molecular mechanism and regulation (Review).

Authors:  David R Garrod; Anita J Merritt; Zhuxiang Nie
Journal:  Mol Membr Biol       Date:  2002 Apr-Jun       Impact factor: 2.857

5.  Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs.

Authors:  Takefumi Kikuchi; Yataro Daigo; Toyomasa Katagiri; Tatsuhiko Tsunoda; Koichi Okada; Soji Kakiuchi; Hitoshi Zembutsu; Yoichi Furukawa; Masafumi Kawamura; Koichi Kobayashi; Kohzoh Imai; Yusuke Nakamura
Journal:  Oncogene       Date:  2003-04-10       Impact factor: 9.867

6.  Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles.

Authors:  Koh Miura; Elise D Bowman; Richard Simon; Amy C Peng; Ana I Robles; Raymond T Jones; Toyomasa Katagiri; Ping He; Hiroki Mizukami; Lu Charboneau; Takefumi Kikuchi; Lance A Liotta; Yusuke Nakamura; Curtis C Harris
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

7.  Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.

Authors:  Dennis A Wigle; Igor Jurisica; Niki Radulovich; Melania Pintilie; Janet Rossant; Ni Liu; Chao Lu; James Woodgett; Isolde Seiden; Michael Johnston; Shaf Keshavjee; Gail Darling; Timothy Winton; Bobby-Joe Breitkreutz; Paul Jorgenson; Mike Tyers; Frances A Shepherd; Ming Sound Tsao
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

8.  Diversity of gene expression in adenocarcinoma of the lung.

Authors:  M E Garber; O G Troyanskaya; K Schluens; S Petersen; Z Thaesler; M Pacyna-Gengelbach; M van de Rijn; G D Rosen; C M Perou; R I Whyte; R B Altman; P O Brown; D Botstein; I Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

9.  Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling.

Authors:  Sunil Singhal; Kunjlata M Amin; Robert Kruklitis; Peter DeLong; Michael E Friscia; Leslie A Litzky; Mary E Putt; Larry R Kaiser; Steven M Albelda
Journal:  Cancer Biol Ther       Date:  2003 May-Jun       Impact factor: 4.742

10.  Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Authors:  David G Beer; Sharon L R Kardia; Chiang-Ching Huang; Thomas J Giordano; Albert M Levin; David E Misek; Lin Lin; Guoan Chen; Tarek G Gharib; Dafydd G Thomas; Michelle L Lizyness; Rork Kuick; Satoru Hayasaka; Jeremy M G Taylor; Mark D Iannettoni; Mark B Orringer; Samir Hanash
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

View more
  21 in total

Review 1.  Genomics of lung cancer.

Authors:  Alain C Borczuk; Rebecca L Toonkel; Charles A Powell
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

2.  Id2 complexes with the SNAG domain of Snai1 inhibiting Snai1-mediated repression of integrin β4.

Authors:  Cheng Chang; Xiaofang Yang; Bryan Pursell; Arthur M Mercurio
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

3.  Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.

Authors:  Rachel L Stewart; Dava West; Chi Wang; Heidi L Weiss; Tamas Gal; Eric B Durbin; William O'Connor; Min Chen; Kathleen L O'Connor
Journal:  Hum Pathol       Date:  2016-04-20       Impact factor: 3.466

Review 4.  Clinical significance of the integrin α6β4 in human malignancies.

Authors:  Rachel L Stewart; Kathleen L O'Connor
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

5.  No evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer.

Authors:  Dominik Riss; Johannes Pammer; Matthaeus C Grasl; Alexandra Kaider; Sven Schneider; Boban M Erovic
Journal:  Wien Klin Wochenschr       Date:  2014-10-10       Impact factor: 1.704

6.  Loss of Desmocollin 3 in skin tumor development and progression.

Authors:  Jiangli Chen; Charlene O'Shea; James E Fitzpatrick; Maranke I Koster; Peter J Koch
Journal:  Mol Carcinog       Date:  2011-06-16       Impact factor: 4.784

Review 7.  HLA class I: an unexpected role in integrin β4 signaling in endothelial cells.

Authors:  Xiaohai Zhang; Elaine F Reed
Journal:  Hum Immunol       Date:  2012-07-10       Impact factor: 2.850

8.  Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer.

Authors:  Anne-Marie C Dingemans; Vivian van den Boogaart; Bettine A Vosse; Robert-Jan van Suylen; Arjan W Griffioen; Victor L Thijssen
Journal:  Mol Cancer       Date:  2010-06-17       Impact factor: 27.401

9.  Comparison of gene expression profiles in chromate transformed BEAS-2B cells.

Authors:  Hong Sun; Harriet A Clancy; Thomas Kluz; Jiri Zavadil; Max Costa
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 10.  The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Authors:  Tamsin Wesley; Stuart Berzins; George Kannourakis; Nuzhat Ahmed
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.